vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and CS Disco, Inc. (LAW). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $41.2M, roughly 1.5× CS Disco, Inc.). CS Disco, Inc. runs the higher net margin — -20.7% vs -70.9%, a 50.3% gap on every dollar of revenue. On growth, CS Disco, Inc. posted the faster year-over-year revenue change (11.3% vs 8.1%). CS Disco, Inc. produced more free cash flow last quarter ($255.0K vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.
CTKB vs LAW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $41.2M |
| Net Profit | $-44.1M | $-8.5M |
| Gross Margin | 52.9% | 75.1% |
| Operating Margin | -9.0% | -22.4% |
| Net Margin | -70.9% | -20.7% |
| Revenue YoY | 8.1% | 11.3% |
| Net Profit YoY | -557.1% | 66.3% |
| EPS (diluted) | — | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $41.2M | ||
| Q3 25 | $52.3M | $40.9M | ||
| Q2 25 | $45.6M | $38.1M | ||
| Q1 25 | $41.5M | $36.7M | ||
| Q4 24 | $57.5M | $37.0M | ||
| Q3 24 | $51.5M | $36.3M | ||
| Q2 24 | $46.6M | $36.0M | ||
| Q1 24 | $44.9M | $35.6M |
| Q4 25 | $-44.1M | $-8.5M | ||
| Q3 25 | $-5.5M | $-13.7M | ||
| Q2 25 | $-5.6M | $-10.8M | ||
| Q1 25 | $-11.4M | $-11.4M | ||
| Q4 24 | $9.6M | $-25.2M | ||
| Q3 24 | $941.0K | $-9.2M | ||
| Q2 24 | $-10.4M | $-10.8M | ||
| Q1 24 | $-6.2M | $-10.6M |
| Q4 25 | 52.9% | 75.1% | ||
| Q3 25 | 52.7% | 75.5% | ||
| Q2 25 | 52.3% | 74.6% | ||
| Q1 25 | 48.6% | 74.1% | ||
| Q4 24 | 58.5% | 74.2% | ||
| Q3 24 | 56.3% | 73.1% | ||
| Q2 24 | 54.6% | 74.2% | ||
| Q1 24 | 51.3% | 75.1% |
| Q4 25 | -9.0% | -22.4% | ||
| Q3 25 | -17.6% | -35.3% | ||
| Q2 25 | -23.3% | -31.0% | ||
| Q1 25 | -36.1% | -34.4% | ||
| Q4 24 | 5.2% | -70.6% | ||
| Q3 24 | -8.2% | -30.0% | ||
| Q2 24 | -18.3% | -34.4% | ||
| Q1 24 | -23.9% | -34.7% |
| Q4 25 | -70.9% | -20.7% | ||
| Q3 25 | -10.5% | -33.4% | ||
| Q2 25 | -12.2% | -28.4% | ||
| Q1 25 | -27.5% | -31.1% | ||
| Q4 24 | 16.8% | -68.1% | ||
| Q3 24 | 1.8% | -25.3% | ||
| Q2 24 | -22.4% | -30.1% | ||
| Q1 24 | -13.8% | -29.7% |
| Q4 25 | — | $-0.13 | ||
| Q3 25 | — | $-0.22 | ||
| Q2 25 | — | $-0.18 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-0.43 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.18 | ||
| Q1 24 | — | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $114.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $128.1M |
| Total Assets | $461.5M | $173.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $114.6M | ||
| Q3 25 | $93.3M | $113.5M | ||
| Q2 25 | $75.5M | $114.5M | ||
| Q1 25 | $95.3M | $118.8M | ||
| Q4 24 | $98.7M | $129.1M | ||
| Q3 24 | $162.3M | $126.8M | ||
| Q2 24 | $177.9M | $130.0M | ||
| Q1 24 | $168.8M | $148.7M |
| Q4 25 | $341.7M | $128.1M | ||
| Q3 25 | $378.6M | $130.6M | ||
| Q2 25 | $377.6M | $137.9M | ||
| Q1 25 | $379.6M | $142.2M | ||
| Q4 24 | $395.7M | $147.5M | ||
| Q3 24 | $385.5M | $167.3M | ||
| Q2 24 | $389.1M | $170.9M | ||
| Q1 24 | $392.6M | $193.2M |
| Q4 25 | $461.5M | $173.6M | ||
| Q3 25 | $494.9M | $174.8M | ||
| Q2 25 | $493.3M | $164.9M | ||
| Q1 25 | $482.6M | $168.0M | ||
| Q4 24 | $499.5M | $180.3M | ||
| Q3 24 | $491.2M | $194.4M | ||
| Q2 24 | $483.7M | $198.0M | ||
| Q1 24 | $492.1M | $217.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $762.0K |
| Free Cash FlowOCF − Capex | $-1.8M | $255.0K |
| FCF MarginFCF / Revenue | -2.9% | 0.6% |
| Capex IntensityCapex / Revenue | 1.6% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-18.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $762.0K | ||
| Q3 25 | $-3.9M | $-979.0K | ||
| Q2 25 | $108.0K | $-4.2M | ||
| Q1 25 | $-125.0K | $-10.5M | ||
| Q4 24 | $2.0M | $2.1M | ||
| Q3 24 | $13.2M | $-2.9M | ||
| Q2 24 | $6.2M | $-650.0K | ||
| Q1 24 | $4.0M | $-7.3M |
| Q4 25 | $-1.8M | $255.0K | ||
| Q3 25 | $-4.6M | $-2.0M | ||
| Q2 25 | $-1.5M | $-5.2M | ||
| Q1 25 | $-974.0K | $-11.0M | ||
| Q4 24 | $1.1M | $1.5M | ||
| Q3 24 | $12.2M | $-3.7M | ||
| Q2 24 | $5.2M | $-1.3M | ||
| Q1 24 | $3.4M | $-8.0M |
| Q4 25 | -2.9% | 0.6% | ||
| Q3 25 | -8.7% | -5.0% | ||
| Q2 25 | -3.2% | -13.6% | ||
| Q1 25 | -2.3% | -30.1% | ||
| Q4 24 | 1.9% | 4.1% | ||
| Q3 24 | 23.7% | -10.3% | ||
| Q2 24 | 11.0% | -3.6% | ||
| Q1 24 | 7.6% | -22.5% |
| Q4 25 | 1.6% | 1.2% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 2.0% | 1.4% | ||
| Q4 24 | 1.6% | 1.5% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 2.3% | 1.8% | ||
| Q1 24 | 1.3% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
